Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
293 studies found for:    Open Studies | "Pharyngeal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Swallowing Function, Oral Health, and Food Intake in Old Age
Conditions: Dysphagia;   Deglutition Disorders;   Swallowing Disorders;   Quality of Life
Intervention: Other: Oral screen
22 Recruiting Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing
Condition: Dysphagia
Intervention: Procedure: VFSS
23 Recruiting Comparison of Cold Dissection Technique and Needle Monopolar Electrocautery Tonsillectomy
Conditions: Chronic Tonsillitis;   Tonsillectomy;   Tonsillar Hypertrophy
Intervention: Procedure: Tonsillectomy
24 Recruiting Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: CIRT with concurrent chemo arm
25 Recruiting Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: CIRT arm (3GyE per fraction)
26 Recruiting A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck
Conditions: Oropharyngeal Neoplasms;   Head and Neck Cancer
Intervention: Device: Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device
27 Not yet recruiting Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail
Condition: Recurrent and Metastatic Nasopharyngeal Carcinoma
Intervention: Drug: nedaplatin and gemcitabine
28 Not yet recruiting Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel;   Drug: Cisplatin 1;   Drug: Xeloda;   Radiation: IMRT;   Drug: Cisplatin 2
29 Not yet recruiting Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis
Conditions: Chronic Disease;   Nasal Polyposis;   Rhinitis
Intervention: Drug: botox injection Multiguide
30 Recruiting Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Intervention: Dietary Supplement: Healing Elements,Methuselah Medical Technology
31 Not yet recruiting Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
Condition: Periodic Fever
Intervention: Drug: Canakinumab
32 Recruiting Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Valproic acid;   Drug: Valganciclovir
33 Recruiting A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)
Condition: Cancer
Intervention: Drug: ARGX-110
34 Not yet recruiting Mucosal Injury Using Pharyngeal Packing
Condition: Sore Throat
Interventions: Device: Hypopharyngeal packing;   Device: Without Hypopharyngeal packing
35 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
36 Recruiting Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program
Conditions: Attenuated Familial Adenomatous Polyposis;   Deleterious Familial Adenomatous Polyposis
Intervention: Other: Chart Review
37 Recruiting A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors
Condition: Oropharyngeal Tumor
Intervention:
38 Not yet recruiting Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Stomatitis
Interventions: Drug: Oral Ulcer Gargle (FORRAD®);   Drug: Quadruple mixture, composed of dexamethasone, gentamicin, vitamin B12, and procaine
39 Recruiting Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
Condition: Nasal Polyposis
Interventions: Drug: AK001 low dose;   Drug: AK001 high dose;   Drug: Placebo
40 Not yet recruiting Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Radiodermatitis
Interventions: Drug: Medical Radiation Protectants (FORRAD®);   Drug: Trolamine (Biafine)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years